Key Insights

Highlights

Success Rate

85% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

8.7%

4 terminated out of 46 trials

Success Rate

85.2%

-1.3% vs benchmark

Late-Stage Pipeline

15%

7 trials in Phase 3/4

Results Transparency

22%

5 of 23 completed with results

Key Signals

5 with results85% success

Data Visualizations

Phase Distribution

38Total
Not Applicable (9)
Early P 1 (1)
P 1 (9)
P 2 (12)
P 3 (4)
P 4 (3)

Trial Status

Completed23
Unknown7
Recruiting5
Active Not Recruiting4
Terminated4
Not Yet Recruiting2

Trial Success Rate

85.2%

Benchmark: 86.5%

Based on 23 completed trials

Clinical Trials (46)

Showing 20 of 20 trials
NCT02143219Phase 2Completed

Efficacy and Tolerance Evaluation in FOLFIRINOX Dose Adjusted in Elderly Patients With a Metastatic Pancreatic Cancer

NCT07408713Not Yet Recruiting

Neurocognitive Deficit After Paediatric Transplantation: Understanding the Role of Environment and Physical Function

NCT02734069Recruiting

Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLC

NCT04700527Phase 1RecruitingPrimary

The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study

NCT06281886Phase 2Active Not Recruiting

Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell Carcinoma

NCT06542159Phase 2Recruiting

Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer or Pulmonary Oligometastases

NCT06870617Recruiting

Practical Geriatric Assessment (PGA) Implementation Strategies and Correlative Evaluations (PACE-70)

NCT06087718Not ApplicableActive Not Recruiting

Feasibility of the Maastro Applicator in Rectal Cancer

NCT03790631Completed

The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring

NCT03461445Phase 4Completed

Effect of Tacrolimus Formulation on Neurological Side Effects in Older Kidney Transplant Recipients

NCT05605834Not ApplicableCompleted

Assessment of Peroxide Level in Saliva During Teeth Bleaching With 9.5% Hydrogen Peroxide Gel

NCT06044623Phase 3Recruiting

Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients

NCT04879563Phase 2Active Not Recruiting

Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE Project

NCT05277480Phase 2Completed

Apatinib With Ifosfamide Plus Etoposide for Relapsed or Refractory Osteosarcoma (OAIE)

NCT06512298Not Yet Recruiting

Plasticizer Exposure and Its Consequences on Health

NCT02054741Not ApplicableCompleted

Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer

NCT03663881Phase 1CompletedPrimary

Safety Assessment of P2Et Extract in Healthy Voluntary Subjects in Colombia

NCT03612544Not ApplicableCompleted

The ESTxENDS Trial- Substudy on the Effect on Toxins From Using Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cig)

NCT02397434Not ApplicableActive Not RecruitingPrimary

Adjuvant Radiotherapy After Cystectomy for Muscle Invasive Bladder Cancer

NCT04676711Phase 1CompletedPrimary

A Study of GFH312 in Healthy Subjects

Scroll to load more

Research Network

Activity Timeline